ALEXION EUROPE S.A.S.

Italy

All drugs from this manufacturer

  • KANUMA

    It is used to treat patients of all ages with lysosomal acid lipase deficiency (LAL deficiency), a genetic disease that causes liver damage, high blood cholesterol levels, and other complications due to fat accumulation.

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    sebelipase alfa -

    ATC: A16AB14

  • SOLIRIS

    Soliris is used to treat several diseases: paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), refractory generalized Myasthenia Gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD).

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    eculizumab -

    ATC: L04AJ01

  • STRENSIQ

    It is used for the treatment of hypophosphatasia, a hereditary disease that begins in childhood. It serves to replace the missing enzyme (alkaline phosphatase) to manage symptoms and promote bone growth and mineralization.

    Dosage form: solution for injection

    Active substance Dosage
    asfostase alfa -

    ATC: A16AB13

  • ULTOMIRIS

    It is used to treat several diseases: paroxysmal nocturnal hemoglobinuria (PNH) in adults and children weighing more than 10 kg; atypical hemolytic uremic syndrome (aHUS) in adults and children weighing more than 10 kg; generalized myasthenia gravis (gMG) in adults and neuromyelitis optica spectrum disorder (NMOSD) in adults.

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    ravulizumab -

    ATC: L04AJ02

  • VOYDEYA

    It is used to treat adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who are already taking C5 inhibitors (ravulizumab or eculizumab) and who still present with residual hemolytic anemia.

    Dosage form: tablets, film-coated

    Active substance Dosage
    danicopan -
    danicopan -
    danicopan -
    danicopan -

    ATC: L04AJ09